Clinical trial
Rituximab and Combination Chemotherapy With or Without Radiation Therapy in…
NCT00278408 · German High-Grade Non-Hodgkin's Lymphoma Study Group, Other · Completed
Key facts
| NCT number | NCT00278408 |
|---|---|
| Title | Rituximab and Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With B-Cell Non-Hodgkin's Lymphoma |
| Official title | Randomized Study Comparing an Immuno-Chemotherapy With 6 Cycles of the Monoclonal Anti-CD20 Antibody Rituximab in Combination With 6 Cycles of Chemotherapy With CHOP ( Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone) at 21-day Intervals or 14-day Intervals, Both With or Without… |
| Lead sponsor | German High-Grade Non-Hodgkin's Lymphoma Study Group, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Lymphoma |
| Intervention type | Biological, Drug, Radiation |
| Interventions | filgrastim, rituximab, cyclophosphamide, doxorubicin hydrochloride, prednisone, vincristine sulfate, radiation therapy |
| Enrollment | 700 |
| Start date | Jan 2, 2006 |
| Primary completion | Feb 1, 2018 |
| Completion | Feb 1, 2018 |
| First posted | Jan 18, 2006 |
| Last update posted | Aug 26, 2025 |
| Countries | Denmark, Germany, Israel, Italy |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: